Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (Diluted Average) (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $44.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 2.53% to $44.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.7 million through Dec 2025, up 2.53% year-over-year, with the annual reading at $44.7 million for FY2025, 2.53% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $44.7 million in Q4 2025 for Rapid Micro Biosystems, down from $45.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $45.0 million in Q3 2025 to a low of $641371.0 in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $36.3 million across 5 years, with a median of $43.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 6479.33% in 2022 and later grew 1.0% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $19.8 million in 2021, then surged by 114.59% to $42.5 million in 2022, then increased by 1.34% to $43.0 million in 2023, then grew by 1.28% to $43.6 million in 2024, then rose by 2.53% to $44.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for RPID at $44.7 million in Q4 2025, $45.0 million in Q3 2025, and $44.3 million in Q2 2025.